MAM
Sanjay Mehta launches Ananta Quest to reimagine life after 50
MUMBAI: Sanjay Mehta, best known for founding Mirum, a pioneering digital agency, has launched a new venture, Ananta Quest. The platform targets Indians aged 50 to 65 who are grappling with questions of identity, health and purpose.
Ananta Quest is built on three pillars: health (prana), wealth (artha) and community (ekatra). Its aim is to provide structure and action, not just reflection.
Mehta has a record of spotting opportunities early. He created Homeindia.com in 1998, among the country’s first e-commerce sites, and Mirum in 2009, when social media marketing was nascent. His latest project stems from his own exploration of ageing, which he has documented through a content series called What If You Live to Be 100?.
“Even the most accomplished individuals face hard questions after 50,” he said at the launch. “We want to create a trusted space where they can move from ambiguity to reinvention.”
India’s over-50 population is expanding fast. Ventures such as Ananta Quest seek to shift the narrative about ageing, framing later life not as decline but as renewal.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
